Citation Impact
Citing Papers
Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
2009
Barriers to healthcare for transgender individuals
2016 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta‐analysis of case series studies
2012
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Ki67 protein: the immaculate deception?
2002
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
2005
Urine markers for detection and surveillance of bladder cancer
2013
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Defining the role of NMP22 in bladder cancer surveillance
2007
Bone marrow cells regenerate infarcted myocardium
2001 StandoutNature
Urinary cytology has a poor performance for predicting invasive or high‐grade upper‐tract urothelial carcinoma
2011
Photoselective Vaporization of the Prostate: Subgroup Analysis of Men with Refractory Urinary Retention
2006
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
2006 Standout
Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation
2006
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology
2012
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
Tissue Microarray Assessment of Prostate Cancer Tumor Proliferation in African- American and White Men
2000
The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer
2007
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?
2003
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Tissue microarray analysis reveals prognostic significance of syndecan‐1 expression in prostate cancer
2003
Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings
2005
Bladder cancer biomarkers: current developments and future implementation
2007
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Nrk, an X-linked Protein Kinase in the Germinal Center Kinase Family, Is Required for Placental Development and Fetoplacental Induction of Labor
2011 StandoutNobel
Bladder cancer
2016 Standout
Current Role of Lasers in the Treatment of Benign Prostatic Hyperplasia (BPH)
2006
Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique
2009
The polycomb group protein EZH2 is involved in progression of prostate cancer
2002 StandoutNature
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
2012
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
2005 Standout
Comparative Population Genomics of the Ejaculate in Humans and the Great Apes
2013 StandoutNobel
Design, Synthesis, and Characterization of Urokinase Plasminogen-Activator-Sensitive Near-Infrared Reporter
2004
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Consensus Statement on Management of Intersex Disorders
2006 Standout
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Proteomic analysis of human prostasomes
2003
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
2011
The Ki-67 protein: From the known and the unknown
2000 Standout
Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century
2015 Standout
Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors
2009 Nature
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
2003 Standout
Renal cell carcinoma
2017 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
The Diode Laser: A Novel Side-Firing Approach for Laser Vaporisation of the Human Prostate—Immediate Efficacy and 1-Year Follow-Up
2007
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Genomics: a preview of genomic medicine
2008
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
2009 Standout
Urinary Markers in Bladder Cancer
2007
Care of the Transgender Patient: A Survey of Gynecologists' Current Knowledge and Practice
2014 Standout
β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds
2002 Standout
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial
2005 Standout
Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.
2000
Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy
2005
Tumor Markers in the Diagnosis of Primary Bladder Cancer. A Systematic Review
2003
Cytology and Urinary Markers for the Diagnosis of Bladder Cancer
2009
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
56-W Frequency-Doubled Source at 530 nm Pumped by a Single-Mode, Single-Polarization, Picosecond, Yb$^{3+}$-Doped Fiber MOPA
2010
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Disease Tolerance as a Defense Strategy
2012 StandoutScience
The MicroRNA Spectrum in 12 Body Fluids
2010 Standout
Radiofrequency Ablation and Cryoablation of Renal Tumours
2007
Association of uPA, PAI-1, and uPAR in Nipple Aspirate Fluid (NAF) with Breast Cancer
2003
High power fiber lasers: current status and future perspectives [Invited]
2010 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
2001
Understanding New Genetics of Male Infertility
2002
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
Chest Reconstruction and Chest Dysphoria in Transmasculine Minors and Young Adults
2018 Standout
The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review
2015 Standout
Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial
2012
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Systematic Reviews of Diagnostic Test Accuracy
2008
Initial Experiences with a 980 nm Diode Laser for Photoselective Vaporization of the Prostate for the Treatment of Benign Prostatic Hyperplasia
2011
Works of Roberto Casella being referenced
Retroperitoneoscopy-Assisted Cryoablation of Renal Tumors Using Multiple 1.5mm Ultrathin Cryoprobes: A Preliminary Report
2005
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma
2008
Does the Prostate Really Need Androgens to Grow? Transurethral Resection of the Prostate in a Male-to-Female Transsexual 25 Years after Sex-Changing Operation
2005
The prognostic value of cytology and fluorescence in situ hybridization in the follow‐up of nonmuscle‐invasive bladder cancer after intravesical Bacillus Calmette‐Guérin therapy
2009
Urinary levels of urokinase‐type plasminogen activator and its receptor in the detection of bladder carcinoma
2002
Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by Urinary Nuclear Matrix Protein 22 and Cytology
2003
Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer
1998
Soluble Fas—A promising novel urinary marker for the detection of recurrent superficial bladder cancer
2006
Die 80-Watt-Kalium-Titanyl-Phosphat- (KTP-)Laservaporisation der Prostata
2004
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder
2006
Significance of the polyglutamine tract polymorphism in the androgen receptor
2001
Photoselective KTP Laser Vaporization of the Prostate: First Experiences with 65 Procedures
2004
URINARY LEVEL OF NUCLEAR MATRIX PROTEIN 22 IN THE DIAGNOSIS OF BLADDER CANCER: : EXPERIENCE WITH 130 PATIENTS WITH BIOPSY CONFIRMED TUMOR
2000
570 80W high-power KTP laser vaporization of the prostate. Clinical results after 110 consecutive procedures
2004
FOCAL NEUROENDOCRINE DIFFERENTIATION LACKS PROGNOSTIC SIGNIFICANCE IN PROSTATE CORE NEEDLE BIOPSIES
1998
Urine Detection of Survivin is a Sensitive Marker for the Noninvasive Diagnosis of Bladder Cancer
2004
RE: TUMOR MARKERS IN THE DIAGNOSIS OF PRIMARY BLADDER CANCER. A SYSTEMATIC REVIEW
2004
Preoperative Plasma Soluble E-Cadherin Predicts Metastases to Lymph Nodes and Prognosis in Patients Undergoing Radical Cystectomy
2003